APA
Druce K. L., Iqbal K., Watson K. D., Symmons D. P. M., Hyrich K. L. & Kelly C. (2017). Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. : RMD open.
Chicago
Druce Katie L, Iqbal Kundan, Watson Kath D, Symmons Deborah P M, Hyrich Kimme L and Kelly Clive. 2017. Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. : RMD open.
Harvard
Druce K. L., Iqbal K., Watson K. D., Symmons D. P. M., Hyrich K. L. and Kelly C. (2017). Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. : RMD open.
MLA
Druce Katie L, Iqbal Kundan, Watson Kath D, Symmons Deborah P M, Hyrich Kimme L and Kelly Clive. Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic. : RMD open. 2017.